Next Article in Journal
Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients
Next Article in Special Issue
Molecular Mechanisms of Aging and Immune System Regulation in Drosophila
Previous Article in Journal
Occurrence of Aflatoxins in Selected Processed Foods from Pakistan
Previous Article in Special Issue
WIP Remodeling Actin behind the Scenes: How WIP Reshapes Immune and Other Functions
Int. J. Mol. Sci. 2012, 13(7), 8338-8352; doi:10.3390/ijms13078338
Review

Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer

1
, 1
, 1
, 1,2
 and 1,*
Received: 1 June 2012; in revised form: 27 June 2012 / Accepted: 29 June 2012 / Published: 4 July 2012
(This article belongs to the Special Issue Advances in Molecular Immunology)
View Full-Text   |   Download PDF [248 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Endoplasmic reticulum (ER) aminopeptidases ERAP1 and ERAP2 (ERAPs) are essential for the maturation of a wide spectrum of proteins involved in various biological processes. In the ER, these enzymes work in concert to trim peptides for presentation on MHC class I molecules. Loss of ERAPs function substantially alters the repertoire of peptides presented by MHC class I molecules, critically affecting recognition of both NK and CD8+ T cells. In addition, these enzymes are involved in the modulation of inflammatory responses by promoting the shedding of several cytokine receptors, and in the regulation of both blood pressure and angiogenesis. Recent genome-wide association studies have identified common variants of ERAP1 and ERAP2 linked to several human diseases, ranging from viral infections to autoimmunity and cancer. More recently, inhibition of ER peptide trimming has been shown to play a key role in stimulating innate and adaptive anti-tumor immune responses, suggesting that inhibition of ERAPs might be exploited for the establishment of innovative therapeutic approaches against cancer. This review summarizes data currently available for ERAP enzymes in ER peptide trimming and in other immunological and non-immunological functions, paying attention to the emerging role played by these enzymes in human diseases.
Keywords: endoplasmic reticulum aminopeptidases; MHC class I; antigen processing; autoimmunity; viral infection; cancer; cancer immunotherapy endoplasmic reticulum aminopeptidases; MHC class I; antigen processing; autoimmunity; viral infection; cancer; cancer immunotherapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Cifaldi, L.; Romania, P.; Lorenzi, S.; Locatelli, F.; Fruci, D. Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer. Int. J. Mol. Sci. 2012, 13, 8338-8352.

AMA Style

Cifaldi L, Romania P, Lorenzi S, Locatelli F, Fruci D. Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer. International Journal of Molecular Sciences. 2012; 13(7):8338-8352.

Chicago/Turabian Style

Cifaldi, Loredana; Romania, Paolo; Lorenzi, Silvia; Locatelli, Franco; Fruci, Doriana. 2012. "Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer." Int. J. Mol. Sci. 13, no. 7: 8338-8352.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert